Merck Leads the Dow Jones Today Higher as Low-Income Patient Subsidies End

Health care stocks are leading the Dow Jones today as Merck moves to end uncertainty over Obamacare.

Mar 26, 2014 at 1:31PM

The Dow Jones Industrial Average (DJINDICES:^DJI) is up despite mixed reports on the U.S. economy. Merck (NYSE:MRK) is leading the Dow higher after the company said it would no longer subsidize expensive drugs for low-income patients on Obamacare. As of 1:30 p.m. EDT the Dow was up 41 points to 16,409. The S&P 500 (SNPINDEX:^GSPC) was up 11 points to 1,767.

The Dow today is up with 22 of 30 components positive for the day after there were two U.S. economic releases.





Durable goods orders




Durable goods orders Ex-transportation




Markit non-manufacturing flash PMI




Both reports were mixed. The Commerce Department reported durable goods orders came in well above analyst expectations of 1% growth. If you exclude the transportation sector, which includes the volatile jetliner and automobile markets, the numbers don't look nearly as good. Durable goods orders ex-transportation were up just 0.2% in February, below January's 0.9% growth and below analyst expectations of 0.2%. The low number was the result of a 2.8% drop in spending on capital goods, that is the assets businesses use in their production. A drop in capital goods signals lower business spending across the board.

The other report was Markit's advance look at its services purchasing managers index. The index rose to 55.5, above last month's 53.3, signaling a faster expansion in economic activity than last month.


Source: Markit.

While the index is up, a measurement of 55 indicates GDP growth of roughly 2.5%, well below what would be considered desirable in a low interest rate environment. The other slightly worrisome sign was that the measure of new business fell to its lowest level since late 2012, signaling business growth may be slowing. Both these reports are important in that they tell us that the economy's slow growth story continues.

Today's Dow leaders
Today's Dow leader is Merck, up 2.2% to $56.40. Merck and GlaxoSmithKline said they will no longer subsidize expensive drugs for low-income patients on Obamacare. The two pharmaceutical giants are taking this action after a prolonged debate over whether the subsidies are legal. Two regulators, U.S. Department of Health and Human Services and the Centers for Medicare and Medicaid Services, have issued differing opinions over the matter.

 Other Dow pharmaceutical giants Pfizer and Johnson & Johnson (NYSE:JNJ) are also up today. Johnson & Johnson told Bloomberg it thinks the payments are legal. While some attribute Merck's rise today to not paying the subsidies, by that logic Pfizer and Johnson & Johnson should not be up. I suspect the companies are all up as investors see this move by Merck and GlaxoSmithKline as forcing the government into finally ending the uncertainty over the matter. Businesses and investors alike do not like uncertainty and so an end of uncertainty on the matter will be a boon to investors in all of the health care giants, especially those dealing with Obamacare.

Everything you need to know about Obamacare
Obamacare seems complex, but it doesn't have to be. In only minutes, you can learn the critical facts you need to know in a special free report called "Everything You Need to Know About Obamacare." This FREE guide contains the key information and money-making advice that every American must know. Please click here to access your free copy.

Dan Dzombak has no position in any stocks mentioned. The Motley Fool recommends Johnson & Johnson. The Motley Fool owns shares of Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

1 Key Step to Get Rich

Our mission at The Motley Fool is to help the world invest better. Whether that’s helping people overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we can help.

Feb 1, 2016 at 4:54PM

To be perfectly clear, this is not a get-rich action that my Foolish colleagues and I came up with. But we wouldn't argue with the approach.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich" rated The Motley Fool as the #1 place online to get smarter about investing.

"The Motley Fool aims to build a strong investment community, which it does by providing a variety of resources: the website, books, a newspaper column, a radio [show], and [newsletters]," wrote (the clearly insightful and talented) money reporter Kathleen Elkins. "This site has something for every type of investor, from basic lessons for beginners to investing commentary on mutual funds, stock sectors, and value for the more advanced."

Our mission at The Motley Fool is to help the world invest better, so it's nice to receive that kind of recognition. It lets us know we're doing our job.

Whether that's helping the entirely uninitiated overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we want to provide our readers with a boost to the next step on their journey to financial independence.

Articles and beyond

As Business Insider wrote, there are a number of resources available from the Fool for investors of all levels and styles.

In addition to the dozens of free articles we publish every day on our website, I want to highlight two must-see spots in your tour of

For the beginning investor

Investing can seem like a Big Deal to those who have yet to buy their first stock. Many investment professionals try to infuse the conversation with jargon in order to deter individual investors from tackling it on their own (and to justify their often sky-high fees).

But the individual investor can beat the market. The real secret to investing is that it doesn't take tons of money, endless hours, or super-secret formulas that only experts possess.

That's why we created a best-selling guide that walks investors-to-be through everything they need to know to get started. And because we're so dedicated to our mission, we've made that available for free.

If you're just starting out (or want to help out someone who is), go to, drop in your email address, and you'll be able to instantly access the quick-read guide ... for free.

For the listener

Whether it's on the stationary exercise bike or during my daily commute, I spend a lot of time going nowhere. But I've found a way to make that time benefit me.

The Motley Fool offers five podcasts that I refer to as "binge-worthy financial information."

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. It's also featured on several dozen radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable ... and I don't say that simply because the hosts all sit within a Nerf-gun shot of my desk. Rule Breaker Investing and Answers contain timeless advice, so you might want to go back to the beginning with those. The other three take their cues from the market, so you'll want to listen to the most recent first. All are available at

But wait, there's more

The book and the podcasts – both free ... both awesome – also come with an ongoing benefit. If you download the book, or if you enter your email address in the magical box at the podcasts page, you'll get ongoing market coverage sent straight to your inbox.

Investor Insights is valuable and enjoyable coverage of everything from macroeconomic events to investing strategies to our analyst's travels around the world to find the next big thing. Also free.

Get the book. Listen to a podcast. Sign up for Investor Insights. I'm not saying that any of those things will make you rich ... but Business Insider seems to think so.

Compare Brokers